Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer | NEJM
Bevacizumab Progression-free Survival Benefit Upheld in AVEREL Trial - The ASCO Post
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma | NEJM
Impact of Bevacizumab-containing Primary Treatment on Outcome of Recurrent Ovarian Cancer: An Italian Study | Anticancer Research
Safety of bevacizumab in clinical practice for recurrent ovarian cancer: A retrospective cohort study
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study - The
Overall survival and time to treatment failure for patients eligible... | Download Scientific Diagram
IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC - Journal of Thoracic Oncology
Overall survival for patients randomized to receive (A) bevacizumab (n... | Download Scientific Diagram
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial - The Lancet Oncology
Avastin® (bevacizumab) Clinical Trials | MCRC Treatment
Sirtex - Overall Survival
Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial - Annals of Oncology
Overall survival according to the addition of bevacizumab to first-line... | Download Scientific Diagram
Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study - Annals of Oncology
TURANDOT: First-Line Bevacizumab Plus Capecitabine Shows Non-Inferior Overall Survival versus Bevacizumab plus Paclitaxel for Metastatic Breast Cancer | ESMO
a: Overall survival in treatment groups with bevacizumab alone or... | Download Scientific Diagram
Kaplan-Meier curves of: A, overall survival from initiation of... | Download Scientific Diagram
Valganciclovir and bevacizumab for recurrent glioblastoma: A single-institution experience
PLOS ONE: Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy Study
Improved Survival with Bevacizumab in Advanced Cervical Cancer | NEJM
Updated Results From IMbrave150 Underscore the Benefit of Frontline Atezolizumab Plus Bevacizumab in Unresectable HCC
Final Overall Survival Analysis of the Phase III Randomised Trial of Chemotherapy With and Without Bevacizumab for Advanced Cervical Cancer | ESMO
